Artificial Intelligence (AI) in Drug Discovery Market Trends and Overview

The size of the Artificial Intelligence (AI) in Drug Discovery market reached US$ 722.3 million in 2022 and is expected to soar to US$ 11.15 billion by 2030, exhibiting a remarkable compound annual growth rate (CAGR) of 40.8% during the forecast period from 2023 to 2030.

This exponential growth can be attributed to the increasing adoption of AI technologies in the field of drug discovery. AI has revolutionized the pharmaceutical industry by enhancing the efficiency and effectiveness of drug development processes. By leveraging advanced algorithms and machine learning techniques, AI enables researchers to analyze vast amounts of data, identify potential drug candidates, and predict their efficacy with greater accuracy.

The rising demand for personalized medicine and the need to accelerate the drug discovery process have further fueled the adoption of AI in this sector. With AI-powered tools, pharmaceutical companies can streamline their research and development efforts, reduce costs, and expedite the delivery of life-saving medications to patients.

Moreover, the COVID-19 pandemic has underscored the importance of AI in drug discovery. The urgent need for effective treatments and vaccines has prompted researchers to leverage AI algorithms to identify potential drug targets and repurpose existing drugs. This has significantly expedited the development of therapeutics to combat the virus and has highlighted the immense potential of AI in addressing global health challenges.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1011

As the AI in Drug Discovery market continues to expand, various stakeholders, including pharmaceutical companies, research institutions, and technology providers, are investing heavily in AI-driven solutions. Collaborations between pharmaceutical giants and AI startups are becoming increasingly common, fostering innovation and driving the growth of this market.

In conclusion, the Artificial Intelligence in Drug Discovery market is poised for substantial growth in the coming years. The transformative power of AI in revolutionizing drug development processes, coupled with the increasing demand for personalized medicine, is driving the adoption of AI technologies in this sector. With a projected CAGR of 40.8% over the forecast period, this market presents.

KEY MARKET SEGMENTATION:

By Component

• Software
• Services

By Technology

• Machine Learning
• Deep Learning
• Supervised Learning
• Reinforcement Learning
• Unsupervised Learning
• Others Technologies

By End-Use

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Research Centres
• Academic & Government Institutes

By Application

• Excavation and mining
• Immuno-Oncology
• Neurodegenerative Diseases
• Cardiovascular Diseases
• Metabolic Diseases
• Other Applications 

KEY PLAYERS:

The Key Players are IBM Corporation, Microsoft, Google, NVIDIA Corporation, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine, BenevolentAI, Exscientia, Cyclica, BIOAGE, Numerate, NuMedii, Envisagenics, twoXAR, OWKIN, Inc., XtalPi, Verge Genomics, BERG LLC and Other Players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

[email protected],

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com